As part of long-term commitment to supporting global medical device manufacturing, Ireland-based medical equipment company Steris has announced a new ethylene oxide (EO) processing facility in Singapore through a strategic partnership with Tomoe Shokai.

The addition of the EO facility to the Steris network complements its existing electron beam, gamma, X-ray, and microbiological testing services in Kuala Ketil, Kulim, Port Klang, and Rawang, Malaysia; Chonburi, Thailand; and Suzhou, China.

Additional EO processing capacity in Asia furthers commitment to ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future.

Its global EO offering includes sustainable EO sterilisation services, which provides customers with strategies to reduce the EO sterilant used in the sterilisation process to achieve the prescribed Sterility Assurance Level. The programme includes innovative approaches to EO sterilisation, such as cycle design, validation strategy, and process challenge device design, all focused on reducing EO residuals on healthcare products.

The addition of EO capacity in Singapore allows for increased technology-neutral processing options in the APAC region and throughout its global network, and allows to support customers with both routine services and processing redundancy.